Read More

A 2024 Investor Guide To New York’s Cannabis Market Expansion: The MSO Wealth Roadmap

Considering the significant growth potential in New York's cannabis market and the strategic positioning of Multi-State Operators (MSOs) highlighted in Zuanic & Associate's latest report, how might investors capitalize on

CCHWF

Read More

How Much Do Canadians Spend On Marijuana? A Look At Third Quarter 2023 Sales Data

Five years into its legalization, the Canadian cannabis market reveals intriguing regional disparities and growth trends, as highlighted in the latest report from cannabis equity research firm Zuanic & Associates. Despite the usual market drivers like affordability, access, and variety, Canada emerges as an outlier.

ACB

Read More

Analyst Highlights Asset-Backed Cannabis Loans In Chicago Atlantic’s REFI With Overweight Rating

Zuanic & Associates (Z&A) recently initiated coverage of Chicago Atlantic Real Estate Finance Inc. (NASDAQ: REFI) with an Overweight rating.  Chicago Atlantic is an externally managed commercial mortgage real estate investment trust.

AFCG

Read More

Investment Potential: Financial Performance, Portfolio And Growth Of Leading Public Sale-Leaseback Stock In Cannabis

Zuanic & Associates' latest report, which initiates coverage of New Lake Capital Partners (OTC: NLCP) with an Overweight rating explains their motivation. "As of the third quarter of 2023, its net real estate assets were valued at $375 million, a significant increase from $12

ACRHF

Read More

EBITDA Growth And Multi-State Opportunities In Key States Going Legal: Zuanic & Associates’ Insights

Zuanic & Associates' latest report offers a thorough analysis of the financial impacts expected in key U.S. states, including Florida, Minnesota, Ohio, Pennsylvania and Virginia, as they move toward recreational cannabis sales by 2025.

AAWH